TickerFacts.

Agape ATP Corp (ATPC): Cost of Revenue

Annual figures by period end, from SEC filings.

$686.0K
Year ended 2025-12-31
+1.0%
3-year compound annual growth
-2.4%
5-year compound annual growth
$1.20M2018-06-30: $441.4K2019-12-31: $1.20M2020-12-31: $775.9K2021-12-31: $297.3K2022-12-31: $666.0K2023-12-31: $494.5K2024-12-31: $563.6K2025-12-31: $686.0K$686.0K
2018-06-30 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$686.0K+21.7%2026-04-13, From 2025-01-01
2024-12-31$563.6K+14.0%2026-04-13, From 2024-01-01
2023-12-31$494.5K-25.8%2025-03-31, From 2023-01-01
2022-12-31$666.0K+124.0%2024-04-01, From 2022-01-01
2021-12-31$297.3K-61.7%2023-03-31, From 2021-01-01
2020-12-31$775.9K-35.4%2022-07-05, From 2020-01-01
2019-12-31$1.20Mn/a2021-03-31, From 2019-01-01
No annual figure between 2018-06-30 and 2019-12-31.
2018-06-30$441.4Kn/a2020-03-27, From 2017-07-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Agape ATP Corp (ATPC)2025-12-31$686.0K+21.7%
Longduoduo Co Ltd (LDDD)2026-06-30$17.0K-81.4%
EUDA Health Holdings Ltd (EUDA)2025-12-31$3.83M+17.8%
Vsee Health, Inc. (VSEE)2025-12-31$7.26M+123.9%
Strata Critical Medical, Inc. (SRTA)2025-12-31$156.01M+33.1%
Omada Health, Inc. (OMDA)2025-12-31$89.27M+33.4%
GeneDx Holdings Corp. (WGS)2025-12-31$129.37M+16.5%

Compare ATPC, LDDD, EUDA, VSEE side by side · Screen every company in Services-Health Services ↗